City Therapeutics (CTY) IPO deck
City Therapeutics is a clinical-stage biotechnology company developing next-generation RNA interference therapeutics to address thromboembolic, ophthalmic, and hematologic diseases.
City Therapeutics is a clinical-stage biotechnology company developing next-generation RNA interference therapeutics to address thromboembolic, ophthalmic, and hematologic diseases.
%20IPO%20deck){kind=link}